ArticleViruses2026

Predictive Value of Sustained Virologic Response at Week 4 in Patients with Hepatitis C Virus Infection Treated with Sofosbuvir/Velpatasvir.

Gia Landry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.